BRC News

We caught up with Dr Samer Elkhodair, whose team within the emergency department is expanding its research thanks to funding from the UCLH Research Directorate.

Researchers have shown that rogue genetic material called extrachromosomal DNA can drive the survival of some of the most aggressive cancers.

UCLH has been selected by Health Data Research UK (HDRUK) as one of seven partners in the pilot study.

Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.

Care for stroke survivors urgently needs to focus on non-motor outcomes like fatigue, anxiety and reduced social participation, according to a new UCLH and UCL study.

Jane de Tisi talks to us about how her work as a Data Manager supports research by the Epilepsy team at UCL and UCLH.

The trial is being run through the NIHR UCLH Clinical Research Facility, and it is supported by The National Brain Appeal.

We talk to Dr Neil Stone, who will deliver trials thanks to funding from the UCLH Research Directorate awarded earlier this year for research in under-researched areas.

Dr Natalia Dominik is a recent recipient of a Fellowship from the BRC Translational Neuroscience theme.

Cervical cancer patients are significantly more likely to be alive and cancer-free after five years when given a short course of chemotherapy prior to chemoradiation, finds a clinical trial led by researchers from UCL and UCLH.

The scans provide greater patient-personalised detail to aid their treatment.

The support is for areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.

The government funding is to strengthen research in lung cancer and hearing loss.

A new study sought to shed light on how hospital patients are prioritised for postoperative care and what impact that has on their health.

We chat to Dr Dominic Giles about work he will be doing aiming to improve care for patients with neurological diseases through use of artificial intelligence-based tools.